References
- Taylor D., Ho B. J., Fagen J. D. Increased dopamine receptor binding in rat brain by repeated cocaine injections. J. Neuroses Res. 1977; 3: 95–101
- Giannini A. J., Malone D. A., Loiselle R. H. Blunting of TSH‐response to TRH in chronic cocaine and phencyclidine abusers. J. Clin Psychiatry 1987; 48: 25–26
- Gawin F. H., Kleber H. D. Cocaine abuse treatment, Open‐pilot trial with desipramine and lithium carbonate. Arch. Gen Psychiatry 1934; 41: 903–909
- Giannini A. J., Malone D. A., Giannini M. C., Loiselle R. H. Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine. J. Clin. Pharmacol. 1986; 26: 211–214
- Giannini A. J., Billet W. S. Bromocriptine‐desipramine protocol in the treatment of cocaine addiction. J. Clin Pharmacol 1987; 27: 259–264
- Gold M. S., Giannini A. J. Cocaine and Cocaine Addiction. Drugs of Abuse, A. J. Giannini, A. E. Slaby. Medical Economics, Oradell, N. J., In Press
- Giannini A. J., Baumgartel P. S., DiMarzio L. R. Bromocriptine therapy in cocaine withdrawal. J. Clin. Pharmacol 1987; 27: 267–270
- Giannini A. J., Loiselle R. H., Sullivan B. A., Giannini M. C. Comparison of bromocriptine and amantadine in the treatment of acute cocaine withdrawal. Soc. Neurosci Abstracts 1987; 13(1)88
- Giannini A. J., Giannini M. C., Price W. A. Antidotal strategies in phencyclidine intoxication. Int. J. Psychiatry Med. 1984; 14: 315–319
- Giannini A. J., Eighan M. C., Giannini M. C. Comparison of haloperidol and chlopromazine in the treatment of phencyclidine psychosis. J. Clin. Pharmacol 1984; 24: 202–205
- Pradham S., Roy S., Pradham S. N. Currelation of behavioral and neurochemical effects of acute administration of cocaine in rats. Life Sciences, 22: 1737–1744
- Benerjec S. P., Sharma V. K., Kung‐Cheung L. S. Cocaine and d‐amphetamine induce changes in central beta‐adrenergic sensitivity: Effects of acute and chronic drug treatment. Brain Res. 1979; 175: 119–130
- Chanda S. K., Sharma V. K., Banerjec S. P. Beta‐adrenoceptor sensitivity following psychotropic drug treatment. Catecholamines: Basic and Clinical Frontiers, E. Usdin, I. J. Kopin, J. Banhas. Pergamon Press, NY 1979; 586–588
- Whitby L. G., Hertting G., Axelrod J. Effect of cocaine on the disposition of norepinephrine labeled with tritium. Nature 1960; 187: 604–605
- Giannini A. J. Drug abuse and depression: Catecholamine depletion suggested as biological tie between cocaine withdrawal and depression. Nat. Inst. Drug Abuse Notes 1987; 2(2)5
- Dackis C. A., Gold M. S. New concepts in cocaine addiction: The dopamine depletion hypothesis. Clin Psychiatry Quarterly 1986; 9: 29
- Paly D., Jatlow P., VanDyke C. Plasma levels of cocaine in native Peruvian coca chewers. Cocaine 1980s, F. R. Jeri. Pacific Press, Lima 1980; 86–89
- DeWit H., Wise R. A. A blockade of cocaine reinforcement in rats with the dopamine blocker pimozide but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J. Physiol 1977; 31: 195–203
- Angrist B., Lee H. K., Gershon S. The antagonism of amphetamineinduced symptomatology by a neuroleptic. Am. J. Psychiatry 1974; 131: 817
- Goeders N. E., Smith J. E. Cortical dopaminergic involvement in cocaine reinforcement. Science 1983; 221: 773–775
- Raff M. Self‐regulation of membrane receptors. Nature 1976; 295: 265–266
- Taylor D., Ho B. T., Fagen J. D. Increased dopamine receptor binding in rat brain by repeated cocaine injections. Commun. Psychopharmacol 1979; 3: 137–142
- Dackis C. A., Gold M. S. Bromocriptine as treatment of cocaine abuse. Lancet 1985; 9: 1151–2, 8438
- Tennant F. S., Sagherian A. A. Double‐blind comparison of amantadine hydrochloride and bromocriptive mesylate for ambulatory withdrawal from cocaine dependence. Arch Int Med 1987; 147: 109–112